论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Li X, Pei B, Wang H, Tang C, Zhu W, Jin F
Received 19 December 2017
Accepted for publication 5 March 2018
Published 6 June 2018 Volume 2018:11 Pages 3359—3368
DOI https://doi.org/10.2147/OTT.S160313
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Justinn Cochran
Peer reviewer comments 3
Editor who approved publication: Dr Ingrid Espinoza
Objectives: Based on the
functionality of AQP-5 characterized in various physiological processes, our
study aimed to investigate the effect of AQP-5 silencing by siRNA interference
on chemosensitivity of breast cancer cells.
Materials and methods: The expression levels of AQP-5 mRNA in different
experimental groups were measured by reverse transcription PCR. The
chemosensitivity of the cells to adriamycin (ADR) was detected by a CCK-8 kit.
Cell invasion, migration, and apoptosis were assessed. Western blot was used to
detect the expression levels of AQP-5, drug resistance-related protein, and
apoptosis-related protein.
Results: The expression level of AQP-5 in MCF-7/ADR cells
was significantly reduced by AQP-5 siRNA transfection. The invasion and
migration were significantly reduced in MCF-7/ADR after AQP-5 siRNA
interference. AQP-5 silencing significantly increased the chemosensitivity of
MCF-7/ADR cells to ADR and activated caspase-dependent apoptosis in MCF-7/ADR
cells. AQP-5 silencing also decreased the expression levels of drug
resistance-related proteins (P-gp and GST-Π).
Conclusion: The inhibition of AQP-5 expression may reverse
the drug resistance and enhance the chemosensitivity of breast cancer cells.
Keywords: aquaporin 5,
breast cancer, ADR, chemosensitivity, apoptosis